Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
09/25/2012 | US8273959 Corn event PV-ZMGT32(nk603) and compositions and methods for detection thereof |
09/25/2012 | US8273958 Process for the production of arachidonic acid and/or eicosapentaenoic acid |
09/25/2012 | US8273957 Δ-15 desaturase genes suitable for increasing levels of omega-3 fatty acids |
09/25/2012 | US8273956 Method for performing homologous recombination in plants |
09/25/2012 | US8273955 Spontaneous nodulation in plants |
09/25/2012 | US8273954 Genetically transformed plants |
09/25/2012 | US8273953 Antisense DNA of sweetpotato expansin cDNA and method for increasing storage root yield using the same |
09/25/2012 | US8273952 Plants having improved growth characteristics and method for making the same |
09/25/2012 | US8273951 Down-regulation of gene expression using artificial micrornas |
09/25/2012 | US8273950 Polynucleotides encoding phenylpropanoid and flavonoid biosynthetic pathway enzymes in coffee |
09/25/2012 | US8273949 Precise breeding |
09/25/2012 | US8273871 Structurally designed shRNAs |
09/25/2012 | US8273870 Compositions and methods for inhibiting expression of a mutant gene |
09/25/2012 | US8273869 Lipid formulated dsRNA targeting the PCSK9 gene |
09/25/2012 | US8273868 Compositions and methods for inhibiting viral replication |
09/25/2012 | US8273867 Transducible delivery of siRNA by dsRNA binding domain fusions to PTD/CPPS |
09/25/2012 | US8273863 Nucleic acid ladders |
09/25/2012 | US8273858 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
09/25/2012 | US8273724 Melanoma antigens and their use in diagnostic and therapeutic methods |
09/25/2012 | US8273723 Compositions and methods for improved glycoprotein sialylation |
09/25/2012 | US8273722 Enhanced biotherapeutic production using inhibitory RNA |
09/25/2012 | US8273714 ADAMTS13 genes and proteins and variants, and therapeutic compositions and methods of utilizing the same |
09/25/2012 | US8273571 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
09/25/2012 | US8273568 Replication-competent herpes simplex virus mediates destruction of neoplastic cells |
09/25/2012 | US8273562 Method for producing 4-hydroxy-L-isoleucine |
09/25/2012 | US8273558 Fermentive production of four carbon alcohols |
09/25/2012 | US8273556 Aldolase and production process of substituted α-keto acids |
09/25/2012 | US8273553 Production of growth hormone in serum-free cell culture medium for mammalian cells |
09/25/2012 | US8273552 Modified growth hormone polypeptides |
09/25/2012 | US8273551 Use of cytokine receptors as biomarkers and therapeutic targets in human cancer |
09/25/2012 | US8273548 Nucleic acids encoding a human PAP1 polypeptide |
09/25/2012 | US8273546 Processes of producing fermentation products |
09/25/2012 | US8273540 Methods and compositions relating to E3 ring-E2 fusion proteins |
09/25/2012 | US8273528 Methods and compositions for determining methylation profiles |
09/25/2012 | US8273527 Viral variants |
09/25/2012 | US8273358 Activatable clostridial toxins |
09/25/2012 | US8273356 Anti-IgE vaccines |
09/25/2012 | US8273353 Inhibitors of vascular endothelial growth factor activity |
09/25/2012 | US8273350 Antibodies to human IL-1β |
09/25/2012 | US8273344 Plasmid construct comprising cytochrome p450 oxygenase inhibitory oligonucleotides for use in prevention and treatment of cell proliferative disorders |
09/25/2012 | CA2740150C Device, kit and method for pulsing biological samples with an agent and stabilising the sample so pulsed |
09/25/2012 | CA2664137C Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
09/25/2012 | CA2653929C Screening method for prokinetic agent |
09/25/2012 | CA2522994C Nucleic acids and corresponding proteins entitled 109p1d4 useful in treatment and detection of cancer |
09/25/2012 | CA2522438C Delivery of nucleic acids into eukaryotic genomes using in vitro assembled mu transposition complexes |
09/25/2012 | CA2507163C Streptococcus uberis adhesion molecule |
09/25/2012 | CA2492846C Motilide compounds |
09/25/2012 | CA2478049C Humanized antibodies that recognize beta amyloid peptide |
09/25/2012 | CA2477240C Decreased reducing sugars in plants for the reduction of acrylamide production in heated foods |
09/25/2012 | CA2465917C Compositions from the grasses lolium perenne and festuca arundinacea |
09/25/2012 | CA2453295C Novel oligoribonucleotide derivatives for specific inhibition of gene expression |
09/25/2012 | CA2447832C Phage display libraries of human vh fragments |
09/25/2012 | CA2429042C Pd-1 deficient mice and the use |
09/25/2012 | CA2428438C Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases |
09/25/2012 | CA2405268C Dna molecules encoding l-glutamate-gated chloride channels from rhipicephalus sanguineus |
09/25/2012 | CA2403842C Increased production of secreted proteins by recombinant eukaryotic cells |
09/25/2012 | CA2394752C Fluorescent intensity assay for duplex and triplex nucleic acid hybridization in solution utilizing fluorescent intercalators |
09/25/2012 | CA2391522C Method for purifying proteins |
09/25/2012 | CA2390309C Method for synthesizing the nucleic acid |
09/25/2012 | CA2375337C Srsv detection kit |
09/25/2012 | CA2359761C Human and mouse trek-1 potassium channel protein and their use |
09/25/2012 | CA2336236C Mutations in and genomic structure of herg - a long qt syndrome gene |
09/25/2012 | CA2323681C Development of human monoclonal antibodies and uses thereof |
09/25/2012 | CA2319727C Limnanthes oil genes |
09/25/2012 | CA2278178C Practical in vitro sialylation of recombinant glycoproteins |
09/25/2012 | CA2256612C System and methods for monitoring for dna amplification by fluorescence |
09/25/2012 | CA2242903C Amino acid-enriched plant protein reserves, particularly lysine-enriched maize .gamma.-zein, and plants expressing such proteins |
09/25/2012 | CA2229171C Method of modulating gene expression with reduced immunostimulatory response |
09/25/2012 | CA2189778C Use of fas ligand to suppress lymphocyte-mediated immune responses |
09/25/2012 | CA2188061C Immunosuppressant target proteins |
09/20/2012 | WO2012125951A1 Cellulase compositions and methods of using the same for improved conversion of lignocellulosic biomass into fermentable sugars |
09/20/2012 | WO2012125737A2 Methods for increasing carbon fixation |
09/20/2012 | WO2012125720A2 Polypeptides having immunoactivating activity and methods of producing the same |
09/20/2012 | WO2012125712A2 Lung tumor classifier for current and former smokers |
09/20/2012 | WO2012125710A1 Method for improved dna release from binding substrates and/or decreasing pcr inhibition in pathogen detection |
09/20/2012 | WO2012125709A1 Methods for improved dna release from binding substrates and/or decreasing pcr inhibition in pathogen detection |
09/20/2012 | WO2012125688A2 Microbial syntheses of aldehydes and corresponding alcohols |
09/20/2012 | WO2012125677A2 Enzyme with enhanced cellulolytic activity |
09/20/2012 | WO2012125652A2 Antibody and antibody mimetic for visualization and ablation of endogenous proteins |
09/20/2012 | WO2012125626A2 Decorin compositions and use thereof |
09/20/2012 | WO2012125379A1 Compositions, process of preparation of said compositions and method of treating inflammatory diseases |
09/20/2012 | WO2012125220A2 Methods for isolation, identification, and quantification of mirnas |
09/20/2012 | WO2012125182A1 Npp1 fusion proteins |
09/20/2012 | WO2012125005A2 Pol i promoter derived from vero cells and recombinant vector containing same |
09/20/2012 | WO2012124968A2 Method of identifying nucleic acid-containing object |
09/20/2012 | WO2012124965A2 Method for assembling multiple target loci to a single nucleic acid sequence |
09/20/2012 | WO2012124946A2 Method for producing 5-aminovaleric acid using recombinant escherichia coli |
09/20/2012 | WO2012124945A2 Method for producing gamma-aminobutyric acid using recombinant escherichia coli |
09/20/2012 | WO2012124943A2 Recombinant microorganism having ability to produce [lactate-co-glycolate] copolymer from glucose, and method for preparing [lactate-co-glycolate] copolymer using same |
09/20/2012 | WO2012124941A2 Recombinant microorganism having ability to produce polyhydroxyalkanoate containing 2-hydroxybutyrate as monomer, and method for preparing polyhydroxyalkanoate containing 2-hydroxybutyrate as monomer using same |
09/20/2012 | WO2012124896A2 Recombinant silk protein derived from sea anemones, method for manufacturing same, and composition for manufacturing silk fibers including same |
09/20/2012 | WO2012124890A2 Method for preparing meso-2,3-butanediol |
09/20/2012 | WO2012124764A1 Antibody production method |
09/20/2012 | WO2012124752A1 Non-human mammal model for normal tension glaucoma |
09/20/2012 | WO2012124683A1 Novel monoclonal antibody and use thereof as tag antibody |
09/20/2012 | WO2012124681A1 A method for nucleic acid amplification and application thereof |
09/20/2012 | WO2012124668A1 Method for assaying arylsulfatase activity |
09/20/2012 | WO2012124639A1 Modified aminotransferase, gene thereof, and method for producing optically active amino compound using same |
09/20/2012 | WO2012124567A1 Method for producing heterologous protein using yeast having knocked out vps gene |
09/20/2012 | WO2012124520A1 Modified αlpha-glucosidase and applications of same |